Skip to main content
. Author manuscript; available in PMC: 2011 Aug 15.
Published in final edited form as: J Immunol. 2010 Jul 14;185(4):2004–2008. doi: 10.4049/jimmunol.1001176

Figure 2. Rapamycin altered IFN-γ production in antigen-specific T cell populations following pathogen infection.

Figure 2

A, Splenocytes from LM-OVA infected mice, which were either left untreated or treated with rapamycin were restimulated with OVA peptide and stained for the presence of IFN-γ or TNF. B, Treatment with rapamycin resulted in an increase in the number of total IFN-γ+ T cells. C, Splenocytes from mOVA grafted mice, which were untreated or treated with rapamycin, were restimulated with OVA peptide and stained for the presence of IFN-γ or TNF. D, Treatment with rapamycin did not result in an increase in the number of total IFN-γ+ T cells. Experiments were performed three times independently with 5 mice per group.

HHS Vulnerability Disclosure